16th Feb 2012 07:00
RNS Number : 4868X
AstraZeneca PLC
16 February 2012
AstraZeneca PLC
Listing Rule LR 9.6.14 R (2)
David Brennan, Chief Executive Officer of AstraZeneca PLC, is to be appointed as a member of the Supervisory Board of Reed Elsevier NV and as a non-executive director of Reed Elsevier PLC with effect from 1 November 2012, subject to shareholder approval at the respective Reed Elsevier Annual General Meetings to be held on 24 and 25 April 2012. He will also be appointed a non-executive director of Reed Elsevier Group plc.
A C N Kemp
Company Secretary
16 February 2012
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Astrazeneca